Ftse Mib
34.191,79
-0,48%
DAX
19.210,81
-0,17%
S&P 500
5.870,62
-1,32%
NASDAQ
18.680,12
-2,24%
Bitcoin
90.730,24
0,97%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ MiMedx Group Inc (MDXG) MiMedx Group Inc (MDXG) Notizie

MiMedx Group Inc

MDXG
9,20
-0,03 (-0,33%)
16 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/11/202415:15GLOBEMIMEDX’s Advocacy to Rein in Runaway Medicare Spend for Skin..
08/11/202420:17EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
04/11/202414:00GLOBEMIMEDX to Participate in Upcoming Investor Conferences
30/10/202421:56EDGAR2Form 8-K - Current report
30/10/202421:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202421:01GLOBEMIMEDX Announces Third Quarter 2024 Operating and Financial..
14/10/202414:00GLOBEMIMEDX to Host Third Quarter 2024 Operating and Financial..
08/10/202422:01GLOBEMIMEDX Points to The New York Times Article on the Vast..
01/10/202422:01GLOBEMIMEDX Showcases Leading Allograft Portfolio and Its Latest..
11/9/202419:03PRNUSEX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE..
04/9/202422:23PRNUSTHIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING..
27/8/202414:00GLOBEMIMEDX to Participate in Upcoming Investor Conferences
26/8/202415:30PRNUSDEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION"..
31/7/202422:11EDGAR2Form 8-K - Current report
31/7/202422:02GLOBEMIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen..
31/7/202422:01GLOBEMIMEDX Announces Second Quarter 2024 Operating and Financial..
31/7/202422:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
22/7/202414:10GLOBEMIMEDX Announces Publication Focused on Surgical..
17/7/202414:00GLOBEMIMEDX to Host Second Quarter 2024 Operating and Financial..
10/7/202423:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/6/202422:01GLOBEMIMEDX Announces the Appointment of Kim Moller to Chief..
07/6/202422:00EDGAR2Form 8-K - Current report
06/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202414:00GLOBEMIMEDX to Participate in Upcoming Investor Conferences
10/5/202400:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/4/202422:01GLOBEMIMEDX Announces First Quarter 2024 Operating and Financial..
16/4/202414:00GLOBEMIMEDX to Host First Quarter 2024 Operating and Financial..
27/3/202413:00GLOBEMIMEDX Provides Update on AXIOFILL® Request for Designation..
20/3/202412:00GLOBEMIMEDX Expands Portfolio with Fibrillar Collagen Wound..
13/3/202413:00GLOBEMIMEDX Introduces E-Commerce and Account Management Platform
06/3/202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202400:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202400:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202414:11EDGAR2Form 8-K - Current report
04/3/202414:00GLOBEMIMEDX Announces Appointment of Two New Independent..
28/2/202422:22EDGAR2Form 8-K - Current report
28/2/202422:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202422:01GLOBEMIMEDX Announces Fourth Quarter and Full Year 2023 Operating..
21/2/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202421:55EDGAR2Form 144 - Report of proposed sale of securities
20/2/202414:00GLOBEMIMEDX to Present at TD Cowen 44th Annual Health Care..
16/2/202422:37EDGAR2Form 144 - Report of proposed sale of securities
16/2/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202421:11EDGAR2Form 144 - Report of proposed sale of securities
14/2/202422:13EDGAR2Form 144 - Report of proposed sale of securities
12/2/202414:00GLOBEMIMEDX to Host Fourth Quarter and Full Year 2023 Operating..
22/1/202414:09EDGAR2Form 8-K - Current report
22/1/202414:00GLOBEMIMEDX Announces Improved Capital Structure with New Senior..
Apertura: 9,30 Min: 8,96 Max: 9,475
Chiusura: 9,23

La tua Cronologia

NASDAQ
MDXG
MiMedx
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network